Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?
about
Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women.Coronary heart disease and depression: a review of recent mechanistic research.Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression.Risk of placental abruption in relation to maternal depressive, anxiety and stress symptoms.Epidemiology and treatment of depression in patients with chronic medical illness.Psychobiology of depression/distress in congestive heart failureReflections on relevance: Psychotherapy and Psychosomatics in 2004.Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregiversAssociation between intimate partner violence, migraine and probable migraineDepression and chronic diseases: it is time for a synergistic mental health and primary care approach.Influence of mental stress on platelet bioactivity.Platelet function in patients with major depression.Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers.Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater.Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs.Intervention of the Nuss Procedure on the Mental Health of Pectus Excavatum Patients.The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro.Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater.Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants.The changes of aggregability of blood platelets in schizophrenia.Longitudinal platelet reactivity to acute psychological stress among older men and women.Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important.Relationship between psychological distress and endogenous anticoagulants in patients with a previous venous thromboembolic event.Depression and coronary heart disease.Pattern of Depression Among Patients of Myocardial Infarction in Karachi, Pakistan: A Cross-sectional Study
P2860
Q30248607-D14C9860-257A-4BF1-978F-30442DD09F1CQ33266570-44534494-E849-467D-92F0-905BE230A6BEQ33953523-82CB4358-3AD8-41DA-A32B-FD06E6FF5524Q34367670-81CB8730-BADD-484B-9A3F-501B25382442Q35237231-B5DBB273-D8FF-4C0F-861E-6F239DAD64CCQ35293910-8700E9B3-B919-425C-9601-106FBA73C4D6Q35997740-9DA48A9E-13E2-4022-BEDC-41A7FB57A33EQ36572299-EAB6DBB9-4BDE-44CE-AD60-295C70101D7BQ36741141-42688E56-671F-42BF-AF08-C3A875F3634EQ36870737-D96A159D-AB21-457F-9749-698E152CAD63Q37070407-6B5A5F97-B0D9-423E-B4AC-BE7E0B8322D0Q37195332-0C2FAA1B-F43A-404B-966F-5DC1B2250E0BQ37394309-0CCDA3C9-063E-4F93-BAED-A3B40A587233Q37409451-31CA1468-7481-4E57-8D4B-FAF389369C4DQ37860257-B7A4BC85-C67F-4DC7-9B48-3B9C5F0C16FDQ38816985-790DE301-A4F8-4774-B908-F48C52A88F5DQ41505334-5D0CF969-4AA8-4847-9CEF-5DFEF98831F8Q43135408-4676319D-DD90-4F5E-AA57-19FF8F524228Q43292681-F7379C34-774D-4C0F-BB66-C49419F2FE7FQ43872474-E645089E-A2BE-48B8-8490-74511A49903CQ44906190-5ED0A440-379D-4960-8499-CC1B1FB07E08Q45975069-ADFE90E6-13D8-4B15-AB89-EB08379E55FEQ46190092-30135935-4F12-4C6A-9D5E-E5992B2095BFQ48797715-EEAA9734-A92C-4E4D-A1BD-5A741489C39BQ50701503-BAEA3EB9-1D33-49FA-8EC4-61A582B86084Q53131906-C889FAFF-85C2-48B9-A12A-7AF2F176B51FQ58564455-9C5446EF-1CBC-4A2B-B067-588F3C80B6CE
P2860
Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@ast
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@en
type
label
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@ast
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@en
prefLabel
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@ast
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@en
P2860
P1476
Platelet hyperactivity in clin ...... t: how strong is the evidence?
@en
P2093
von Känel R
P2860
P304
P356
10.1111/J.1600-0447.2004.00308.X
P407
P577
2004-09-01T00:00:00Z